# Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations

> **NCT03691870** · NA · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 77 (actual)

## Conditions studied

- Arteriovenous Malformations, Cerebral
- Unruptured Brain Arteriovenous Malformation
- Ruptured Brain Arteriovenous Malformation

## Interventions

- **PROCEDURE:** Standard Trans-Arterial Embolization (TAE)
- **PROCEDURE:** Trans-Venous Embolization (TVE)

## Key facts

- **NCT ID:** NCT03691870
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-02
- **Primary completion:** 2025-01-24
- **Final completion:** 2025-07-23
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691870, "Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03691870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*